I agree that this site is using cookies. You can find further informations here.
X
Viljoen, Adie
45  results:
OpenAccess-fulltext X
Search for persons X
?
1

Time to Reach Glycaemic and Body Weight Loss Thresholds wit..:

Viljoen, Adie ; Pantalone, Kevin M ; Galindo, Rodolfo J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126190/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Meeting the Challenge of Virtual Diabetes Care: A Consensus..:

Evans, Marc ; Morgan, Angharad R ; Bain, Stephen C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767360/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Abstract 10: Efficacy and safety of semaglutide 2.4 mg once..:

Rahman, Syed Kasfur ; Davies, Melanie ; Færch, Louise...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067799/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

The long-term cost-effectiveness of once-weekly semaglutide..:

Viljoen, Adie ; Chubb, Barrie ; Malkin, Samuel J. P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290607/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

The Place and Value of Sodium-Glucose Cotransporter 2 Inhib..:

Wilding, John PH ; Evans, Marc ; Fernando, Kevin...
doi:10.17863/CAM.83710.  , 2022
Link: https://doi.org/10.17863..
 
?
6

The Place and Value of Sodium-Glucose Cotransporter 2 Inhib..:

Wilding, John P. H ; Evans, Marc ; Fernando, Kevin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934539/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Elevated Lipoprotein(a): Background, Current Insights and F..:

Handhle, Ahmed ; Viljoen, Adie ; Wierzbicki, Anthony S
info:eu-repo/semantics/altIdentifier/doi/10.2147/VHRM.S266244.  , 2021
Link: https://www.dovepress.co..
 
?
8

An indirect treatment comparison of the efficacy of semaglu..:

Pratley, Richard E ; Catarig, Andrei‐Mircea ; Lingvay, Ildiko...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291551/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Efficacy and Safety of Semaglutide 2.4 MG Once-Weekly in Ad..:

Davies, Melanie ; Færch, Louise ; Jeppesen, Ole K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089158/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Elevated Lipoprotein(a): Background, Current Insights and F..:

Handhle, Ahmed ; Viljoen, Adie ; Wierzbicki, Anthony S
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436116/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progres..:

Wheeler, David C ; James, June ; Patel, Dipesh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524028/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Tran..:

Ali, Amar ; Bain, Steve ; Hicks, Debbie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778582/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
13

Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Be..:

Ali, Amar ; Bain, Steve ; Hicks, Debbie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778550/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
14

IDegLira improves patient-reported outcomes while using a s..:

Miller, Eden ; Doshi, Ankur ; Grøn, Randi...
Miller, E., Doshi, A., Grøn, R., Jódar, E., Őrsy, P., Ranthe, M. F., Sugimoto, D. Nikolaos Tentolouris, N., Viljoen, A. & Billings, L. K. (2019). IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy. Diabetes, Obesity and Metabolism, 21(12), 2643-2650. https://doi.org/10.1111/dom.13851.  , 2019
Link: http://hdl.handle.net/11..
 
?
15

IDegLira improves patient‐reported outcomes while using a s..:

Miller, Eden ; Doshi, Ankur ; Grøn, Randi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899651/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
1-15